Venous thromboembolism in patients with advanced cancer under palliative care: Additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice

Palliative Medicine

Volumn 22, Issue 8, 2008, Pages 965-968

  Soto Cardenas M J ^a   Pelayo Garcia G ^a   Rodriguez Camacho A ^a   Segura Fernandez E ^a   Mogollo Galvan A ^a   Giron Gonzalez, J A ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Advanced cancer; Palliative care; Venous thromboembolism

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADVANCED CANCER; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CLINICAL PRACTICE; DRUG WITHDRAWAL; FATALITY; FEMALE; HUMAN; IMMOBILIZATION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIMARY PREVENTION; RECOMMENDED DRUG DOSE; RECURRENCE RISK; RISK FACTOR; SECONDARY PREVENTION; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PALLIATIVE CARE; RETROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 57149136469     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269216308098803     Document Type: Article

References (16)

1. Lee AY, Levine MN. Venous thromboembolism and cancer: Risks and outcomes. Circulation 2003; 107: I17-I21.
2. Johnson MJ, Walker ID, Sproule MW, Conkie J. Abnormal coagulation and deep venous thrombosis in patients with advanced cancer. Clin Lab Haematol 1999; 21: 51-54.
3. Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Cancer Metastasis Rev 1992; 11: 237-248.
4. Johnson MJ, Sproule MW, Paul J. The prevalence and associated variables of deep venous thrombosis in patients with advanced cancer. Clin Oncol (R Coll Radiol) 1999; 11: 105- 110.
5. Monreal M, Falga C, Valdes M, Suárez C, Gabriel F, Tolosa C. Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: Findings from the RIETE registry. J Thromb Haemost 2006; 4: 1950-1956.
6. Noble SI, Shelley MD, Coles B, Williams SM, Wilcock A, Johnson MJ. Management of venous thromboembolism in patients with advanced cancer: A systematic review and meta-analysis. Lancet Oncol 2008; 9: 577- 584
7. Johnson MJ, Sherry K. How do palliative physicians manage venous thromboembolism. Palliat Med 1997; 11: 462-468.
8. Noble SI, Finlay IG. Have palliative care teams' attitudes toward venous thromboembolism changed? A survey of thromboprophylaxis practice across British specialist palliative care units in the years 2000 and 2005. J Pain Symptom Manage 2006; 32: 38-43.
9. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA. Prevention of venous thromboembolism. Chest 2001; 119 (Suppl 1): 132S-175S.
10. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 338S-400S.
11. 11 The Columbus Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997; 337: 657- 662.
12. Mandala M, Falanga A, Piccioli A, Prandoni P, Pogliani EM, Labianca R. Venous thromboembolism and cancer: Guidelines of the Italian Association of Medical Oncology (AIOM). Crit Rev Oncol Hematol 2006; 59: 194- 204.
13. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 401S-428S.
14. Noble SI, Finlay IG. Is long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative study. Palliat Med 2005; 19: 197- 201.
15. Noble SI, Hood K, Finlay IG. The use of long-term low-molecular weight heparin for the treatment of venous thromboembolism in palliative care patients with advanced cancer: A case series of sixty two patients. Palliat Med 2007; 21: 473-476.
16. Monreal M, Zacharski L, Jimenez JA, Roncales J, Vilaseca B. Fixed-dose low-molecular-weight heparin for secondary prevention of venous thromboembolism in patients with disseminated cancer: A prospective cohort study. J Thromb Haemost 2004; 2: 1311-1315.